首站-论文投稿智能助手
典型文献
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
文献摘要:
The use of small interfering RNAs(siRNAs)has been under investigation for the treatment of several unmet medical needs,including acute lung injury/acute respiratory distress syndrome(ALI/ARDS)wherein siRNA may be implemented to modify the expression of pro-inflammatory cytokines and chemokines at the mRNA level.The properties such as clear anatomy,accessibility,and relatively low enzyme activity make the lung a good target for local siRNA therapy.However,the translation of siRNA is restricted by the inefficient delivery of siRNA therapeutics to the target cells due to the prop-erties of naked siRNA.Thus,this review will focus on the various delivery systems that can be used and the different barriers that need to be surmounted for the development of stable inhalable siRNA formu-lations for human use before siRNA therapeutics for ALI/ARDS become available in the clinic.
文献关键词:
作者姓名:
Makhloufi Zoulikha;Qingqing Xiao;George Frimpong Boafo;Marwa A.Sallam;Zhongjian Chen;Wei He
作者机构:
Department of Pharmaceutics,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Department of Industrial Pharmacy,Faculty of Pharmacy,Alexandria University,Alexandria 21521,Egypt;Shanghai Skin Disease Hospital,Tongji University School of Medicine,Shanghai 200443,China
引用格式:
[1]Makhloufi Zoulikha;Qingqing Xiao;George Frimpong Boafo;Marwa A.Sallam;Zhongjian Chen;Wei He-.Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome)[J].药学学报(英文版),2022(02):600-620
A类:
surmounted
B类:
Pulmonary,delivery,against,acute,lung,injury,respiratory,distress,syndrome,small,interfering,siRNAs,has,been,under,investigation,treatment,several,unmet,medical,needs,including,ALI,ARDS,wherein,may,implemented,modify,expression,inflammatory,cytokines,chemokines,level,properties,such,clear,anatomy,accessibility,relatively,low,enzyme,activity,make,good,target,local,therapy,However,translation,restricted,by,inefficient,therapeutics,cells,due,naked,Thus,this,review,will,focus,various,systems,that,can,used,different,barriers,development,stable,inhalable,formu,lations,human,before,become,available,clinic
AB值:
0.601972
相似文献
Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages
Yu Han;Yuming Yang;Qiuyang Sun;Bin Li;Caixia Yue;Yanlei Liu;Jesús M.de la Fuente;Daxiang Cui-Institute of Nano Biomedicine and Engineering,Key Laboratory for Thin Film and Microfabrication Technology of the Ministry of Education,Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument,Department of Instrument Science&Engineering,School of Electronic Information and Electrical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China;National Engineering Center for Nanotechnology,Collaborative Innovational Center for System Biology,Shanghai 200241,China;Department of Neurosurgery,Xinhua Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200092,China;School of Biomedical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China;Instituto de Nanociencia de Aragon(INA),Universidad de Zaragoza,Zaragoza 50018,Spain
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid,prolonged,and broad protection against SARS-CoV-2
Junyu Chen;Pui Wang;Lunzhi Yuan;Liang Zhang;Limin Zhang;Hui Zhao;Congjie Chen;Xijing Wang;Jinle Han;Yaode Chen;Jizong Jia;Zhen Lu;Junping Hong;Zicen Lu;Qian Wang;Rirong Chen;Ruoyao Qi;Jian Ma;Min Zhou;Huan Yu;Chunlan Zhuang;Xiaohui Liu;Qiangyuan Han;Guosong Wang;Yingying Su;Quan Yuan;Tong Cheng;Ting Wu;Xiangzhong Ye;Tianying Zhang;Changgui Li;Jun Zhang;Huachen Zhu;Yixin Chen;Honglin Chen;Ningshao Xia-State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,National Institute of Diagnostics and Vaccine Development in Infectious Diseases,School of Life Sciences,School of Public Health,Xiamen University,Xiamen 361102,China;State Key Laboratory of Emerging Infectious Diseases,School of Public Health,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China;National Institute for Food and Drug Control,Beijing 102629,China;Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd.,Beijing 102206,China;Guangdong-Hong Kong Joint Laboratory of Emerging Infectious Diseases/Joint Laboratory for International Collaboration in Virology and Emerging Infectious Diseases,Joint Institute of Virology(STU/HKU),Shantou University,Shantou 515063,China;EKIH Pathogen Research Institute,Shenzhen 518067,China
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
Jia Lu;Qiangling Yin;Rongjuan Pei;Qiu Zhang;Yuanyuan Qu;Yongbing Pan;Lina Sun;Ding Gao;Cuiqin Liang;Jingwen Yang;Wei Wu;Jiandong Li;Zongqiang Cui;Zejun Wang;Xinguo Li;Dexin Li;Shiwen Wang;Kai Duan;Wuxiang Guan;Mifang Lian;Xiaoming Yang-National Engineering Technology Research Center for Combined Vaccines,Wuhan Institute of Biological Products Co.Ltd.,Wuhan,430070,China;State Key Laboratory for Molecular Virology and Genetic Engineering National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing,102206,China;Center for Emerging Infectious Diseases,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China;CDC-WIV Joint Research Center for Emerging Diseases and Biosafety,Wuhan,430071,China;Institution of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518107,China
Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
Ya-li Zhang;Wen-xin Zhang;Jue-qian Yan;Ye-lin Tang;Wen-jing Jia;Zheng-wei Xu;Ming-jiang Xu;Nipon Chattipakorn;Yi Wang;Jian-peng Feng;Zhi-guo Liu;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai 264005,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Zhuji Biomedicine Institute,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhuji 311800,China;Cardiac Electrophysiology Research and Training Center,Faculty of Medicine,Chiang Mai University,Chiang Mai 50200,Thailand;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。